Guggenheim Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,123
Closed -$67.8K 1957
2022
Q4
$67.8K Sell
27,123
-5,260
-16% -$13.2K ﹤0.01% 1886
2022
Q3
$137K Sell
32,383
-28,587
-47% -$121K ﹤0.01% 1824
2022
Q2
$170K Sell
60,970
-4,918
-7% -$13.7K ﹤0.01% 1965
2022
Q1
$376K Buy
65,888
+663
+1% +$3.78K ﹤0.01% 1785
2021
Q4
$596K Buy
65,225
+453
+0.7% +$4.14K ﹤0.01% 1602
2021
Q3
$692K Sell
64,772
-182
-0.3% -$1.94K ﹤0.01% 1608
2021
Q2
$1.01M Buy
64,954
+6,539
+11% +$101K 0.01% 1486
2021
Q1
$947K Buy
58,415
+24,677
+73% +$400K 0.01% 1427
2020
Q4
$714K Buy
33,738
+12,174
+56% +$258K ﹤0.01% 1489
2020
Q3
$320K Buy
+21,564
New +$320K ﹤0.01% 1610
2019
Q4
Sell
-94,895
Closed -$1.76M 2103
2019
Q3
$1.76M Sell
94,895
-14,556
-13% -$269K 0.01% 1070
2019
Q2
$2.03M Sell
109,451
-3,665
-3% -$68.1K 0.02% 1041
2019
Q1
$2.76M Buy
113,116
+11,722
+12% +$286K 0.02% 930
2018
Q4
$2.63M Buy
101,394
+95,058
+1,500% +$2.47M 0.02% 904
2018
Q3
$201K Buy
+6,336
New +$201K ﹤0.01% 2331
2017
Q4
Sell
-143,840
Closed -$2.32M 2756
2017
Q3
$2.32M Buy
143,840
+26,657
+23% +$430K 0.01% 1555
2017
Q2
$1.62M Buy
117,183
+5,075
+5% +$70.3K ﹤0.01% 1773
2017
Q1
$1.68M Buy
112,108
+10,039
+10% +$151K ﹤0.01% 1784
2016
Q4
$1.34M Buy
102,069
+9,339
+10% +$122K ﹤0.01% 1972
2016
Q3
$1.6M Sell
92,730
-5,652
-6% -$97.4K 0.01% 1769
2016
Q2
$1.78M Sell
98,382
-6,235
-6% -$113K 0.01% 1637
2016
Q1
$1.99M Buy
104,617
+20,397
+24% +$387K 0.01% 1575
2015
Q4
$2.25M Buy
84,220
+35,848
+74% +$957K 0.01% 1529
2015
Q3
$1.18M Buy
+48,372
New +$1.18M ﹤0.01% 1991